-+ 0.00%
-+ 0.00%
-+ 0.00%

Climb Bio Q1 EPS $(0.31) Misses $(0.15) Estimate

Benzinga·05/14/2025 11:12:12
Listen to the news
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.15) by 106.67 percent. This is a 416.67 percent decrease over losses of $(0.06) per share from the same period last year.